Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history

被引:58
作者
Arora, Harneet [1 ]
Willcocks, Rebecca J. [1 ]
Lott, Donovan J. [1 ]
Harrington, Ann T. [2 ]
Senesac, Claudia R. [1 ]
Zilke, Kirsten L. [3 ]
Daniels, Michael J. [4 ]
Xu, Dandan [5 ]
Tennekoon, Gihan I. [2 ]
Finanger, Erika L. [3 ]
Russman, Barry S. [3 ]
Finkel, Richard S. [6 ]
Triplett, William T. [1 ]
Byrne, Barry J. [7 ]
Walter, Glenn A. [8 ]
Sweeney, H. Lee [9 ]
Vandenborne, Krista [1 ]
机构
[1] Univ Florida, Dept Phys Therapy, UFHSC, Box 100154, Gainesville, FL 32610 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Florida, Dept Stat, Gainesville, FL 32611 USA
[5] Univ Texas Austin, Dept Stat & Data Sci, Austin, TX 78712 USA
[6] Nemours Childrens Hosp, Orlando, FL USA
[7] Univ Florida, Powell Gene Therapy Ctr, Dept Pediat & Mol Genet & Microbiol, Gainesville, FL USA
[8] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA
[9] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA
基金
美国国家卫生研究院;
关键词
6-minute walk test; ambulatory function; Duchenne muscular dystrophy; functional endpoints; loss of ambulation; outcome measures; 6-MINUTE WALK TEST; OUTCOME MEASURE; END-POINTS; MRI;
D O I
10.1002/mus.26161
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Tests of ambulatory function are common clinical trial endpoints in Duchenne muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large data set that can describe the contemporary natural history of DMD in 5-12.9-year-olds. Methods: Ninety-two corticosteroid-treated boys with DMD and 45 controls participated in this longitudinal study. Participants performed the 6-minute walk test (6MWT) and timed function tests (TFT: 10-m walk/run, climbing 4 stairs, supine to stand). Results: Boys with DMD had impaired functional performance even at 5-6.9 years old. Boys older than 7 had significant declines in function over 1 year for 10-m walk/run and 6MWT. Eighty percent of participants could perform all functional tests at 9 years old. TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds. Discussion: This study provides insight into the contemporary natural history of key functional endpoints in DMD. Muscle Nerve 58: 631-638, 2018
引用
收藏
页码:631 / 638
页数:8
相关论文
共 24 条
[1]  
Alfano LN, 2014, NEUROMUSCULAR DISORD, V24, P1
[2]   Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS [J].
Arpan, Ishu ;
Willcocks, Rebecca J. ;
Forbes, Sean C. ;
Finkel, Richard S. ;
Lott, Donovan J. ;
Rooney, William D. ;
Triplett, William T. ;
Senesac, Claudia R. ;
Daniels, Michael J. ;
Byrne, Barry J. ;
Finanger, Erika L. ;
Russman, Barry S. ;
Wang, Dah-Jyuu ;
Tennekoon, Gihan I. ;
Walter, Glenn A. ;
Sweeney, H. L. ;
Vandenborne, Krista .
NEUROLOGY, 2014, 83 (11) :974-980
[3]   Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study [J].
Bello, Luca ;
Gordish-Dressman, Heather ;
Morgenroth, Lauren P. ;
Henricson, Erik K. ;
Tina Duong ;
Hoffman, Eric P. ;
Cnaan, Avital ;
McDonald, Craig M. .
NEUROLOGY, 2015, 85 (12) :1048-1055
[4]   Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy [J].
Bonati, Ulrike ;
Hafner, Patricia ;
Schadelin, Sabine ;
Schmid, Maurice ;
Devasia, Arjith Naduvilekoot ;
Schroeder, Jonas ;
Zuesli, Stephanie ;
Pohlman, Urs ;
Neuhaus, Cornelia ;
Klein, Andrea ;
Sinnreich, Michael ;
Haas, Tanja ;
Gloor, Monika ;
Bieri, Oliver ;
Fischmann, Arne ;
Fischer, Dirk .
NEUROMUSCULAR DISORDERS, 2015, 25 (09) :679-685
[5]   CLINICAL-TRIAL IN DUCHENNE DYSTROPHY .1. THE DESIGN OF THE PROTOCOL [J].
BROOKE, MH ;
GRIGGS, RC ;
MENDELL, JR ;
FENICHEL, GM ;
SHUMATE, JB ;
PELLEGRINO, RJ .
MUSCLE & NERVE, 1981, 4 (03) :186-197
[6]  
Bushby Kate, 2011, Clin Investig (Lond), V1, P1217
[7]   ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY [J].
Bushby, Katharine ;
Finkel, Richard ;
Wong, Brenda ;
Barohn, Richard ;
Campbell, Craig ;
Comi, Giacomo P. ;
Connolly, Anne M. ;
Day, John W. ;
Flanigan, Kevin M. ;
Goemans, Nathalie ;
Jones, Kristi J. ;
Mercuri, Eugenio ;
Quinlivan, Ros ;
Renfroe, James B. ;
Russman, Barry ;
Ryan, Monique M. ;
Tulinius, Mar ;
Voit, Thomas ;
Moore, Steven A. ;
Sweeney, H. Lee ;
Abresch, Richard T. ;
Coleman, Kim L. ;
Eagle, Michelle ;
Florence, Julaine ;
Gappmaier, Eduard ;
Glanzman, Allan M. ;
Henricson, Erik ;
Barth, Jay ;
Elfring, Gary L. ;
Reha, Allen ;
Spiegel, Robert J. ;
O'Donnell, Michael W. ;
Peltz, Stuart W. ;
McDonald, Craig M. .
MUSCLE & NERVE, 2014, 50 (04) :477-487
[8]   Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (02) :177-189
[9]   Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (01) :77-93
[10]  
Geiger R, 2007, J PEDIAT, V150